Cancers

Cancers (Basel) · ISSN (print) 2072-6694 · 367 papers in corpus
review 2023
doi:10.3390/cancers15123125 ·PMID:37370735

Ovarian cancer (OC) is the eighth cancer both in prevalence and mortality in women and represents the deadliest female reproductive cancer. Due to generally vague symptoms, OC is frequently diagnosed only at a late and advanced stage, resul…

lab-animal 2023
doi:10.3390/cancers15041315 ·PMID:36831656

The overexpression of inhibitor of apoptosis (IAP) proteins is strongly related to poor survival of women with ovarian cancer. Recurrent ovarian cancers resist apoptosis due to the dysregulation of IAP proteins. Mechanistically, Second Mito…

review 2023
doi:10.3390/cancers15143584 ·PMID:37509250

BACKGROUND: Sarcoma may show similarities to malignant melanoma in terms of morphologic and immunohistochemical aspects, making it difficult to differentiate between these two neoplasms during the diagnostic process. This systematic review …

observational 2023
doi:10.3390/cancers15030833 ·PMID:36765791

The relationship between uterine corpus cancer and endometriosis was conflicting. We aimed to determine the risk of uterine cancer in patients with endometriosis or pelvic inflammatory disease (PID). In this population-based cohort study, a…

review 2023
doi:10.3390/cancers16010040 ·PMID:38201468

Ovarian cancer is the most lethal gynaecological cancer and the eighth most common female cancer. The early diagnosis of ovarian cancer remains a clinical problem despite the significant development of technology. Nearly 70% of patients wit…

review 2023
doi:10.3390/cancers15153872 ·PMID:37568688

The vermiform appendix is a muscular cylindrical structure originating near the junction of the cecum and ileum, averaging 9 cm (5-35 cm) in size. As the most mobile viscera, it can adopt several positions, the most common being the retroce…

review 2023
doi:10.3390/cancers15041232 ·PMID:36831575

RNA modifications are diverse, dynamic, and reversible transcript alterations rapidly gaining attention due to their newly defined RNA regulatory roles in cellular pathways and pathogenic mechanisms. The exciting emerging field of 'epitrans…

diagnostic-accuracy 2023
doi:10.3390/cancers15041256 ·PMID:36831601

The symptoms of ovarian cancer are vague, and current risk assessment tools such as serum CA125 and transvaginal ultrasound scan fail to reliably detect the disease early. This study aimed to evaluate urine CA125 and HE4 as diagnostic bioma…

observational 2022
doi:10.3390/cancers14030747 ·PMID:35159015

Despite high survival, paediatric optic pathway hypothalamic gliomas are associated with significant morbidity and late mortality. Those youngest at presentation have the worst outcomes. We aimed to assess presenting disease, tumour locatio…

observational 2022
doi:10.3390/cancers14225696 ·PMID:36428788

The association between acute pancreatitis (AP) and gastrointestinal cancers in diabetic patients is currently not well understood. The study aim was to investigate the association between AP and gastrointestinal cancers in diabetic patient…

diagnostic-accuracy 2022
doi:10.3390/cancers14215291 ·PMID:36358710

Appropriate clinical management of adnexal masses requires a detailed diagnosis. We retrospectively collected ultrasound images of 1559 cases from the first Center of Chinese PLA General Hospital and developed a fully automatic deep learnin…

review 2022
doi:10.3390/cancers14143517 ·PMID:35884577

Uterine sarcomas are rare malignant tumors of the uterus with a high degree of malignancy. Their clinical manifestations, imaging examination findings, and laboratory test results overlap with those of uterine fibroids. No reliable diagnost…

review 2022
doi:10.3390/cancers14225517 ·PMID:36428610

The globalization and the changes in consumer lifestyles are forcing us to face a deep transformation in food demand and in the organization of the entire food production system. In this new era, the food-loss and food-waste security nexus …

diagnostic-accuracy 2022
doi:10.3390/cancers14246262 ·PMID:36551747

Endometrial cancers (ECs) are mostly adenocarcinomas arising from the inner part of the uterus. The identification of serum biomarkers, either soluble or carried in the exosome, may be useful in making an early diagnosis. We used label-free…

review 2022
doi:10.3390/cancers14163898 ·PMID:36010892

Cancer is a serious and significantly progressive disease. Next to cardiovascular disease, cancer has become the most common cause of mortality in the entire world. Several factors, such as environmental factors, habitual activities, geneti…

lab-animal 2022
doi:10.3390/cancers14184424 ·PMID:36139584

Astragaloside IV (AS-IV) is a chemical found in traditional Chinese medicine called Astragalus membranaceus (Fisch.) Bunge that has antitumor properties. However, the roles and mechanisms of AS-IV in uterine leiomyomas (ULMs) are unclear. T…

review 2022
doi:10.3390/cancers14205056 ·PMID:36291839

Macropinocytosis is an essential mechanism for the non-specific uptake of extracellular fluids and solutes. In recent years, additional functions have been identified in macropinocytosis, such as the intracellular introduction pathway of dr…

other 2022
doi:10.3390/cancers14071651 ·PMID:35406422

Ovarian cancer is a common malignant gynecological disease. Molecular target therapy, i.e., antiangiogenesis with bevacizumab, was found to be effective in some patients of epithelial ovarian cancer (EOC). Although careful patient selection…

diagnostic-accuracy 2022
doi:10.3390/cancers14071780 ·PMID:35406551

Ovarian cancer (OC) is the most lethal genital malignancy in women. We aimed to develop and validate new proteomic-based models for non-invasive diagnosis of OC. We also compared them to the modified Risk of Ovarian Malignancy Algorithm (RO…

review 2022
doi:10.3390/cancers14225711 ·PMID:36428803

Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer, and more than 70% of patients are diagnosed at advanced stages. Despite the application of surgery and chemotherapy, the prognosis remains poor due to the high relapse…

review 2022
doi:10.3390/cancers14081866 ·PMID:35454771

The incidence and prevalence of pancreatic adenocarcinoma have increased in recent years. Pancreatic cancer is the seventh leading cause of cancer death, but it is projected to become the second leading cause of cancer-related mortality by …

review 2022
doi:10.3390/cancers14081889 ·PMID:35454792

Globally, colorectal cancer (CRC) is the third most common cancer, with 1.4 million new cases and over 700,000 deaths per annum. Despite being one of the most common cancers, few molecular approaches to detect CRC exist. Carcinoembryonic an…

review 2022
doi:10.3390/cancers14061543 ·PMID:35326694

The complement system is an important branch of the humoral innate immune response that can be activated via three distinct pathways (classical, alternative, lectin), contributing to keeping/restoring homeostasis. It can also interact with …

other 2022
doi:10.3390/cancers14225572 ·PMID:36428665

Oxidative stress contributes significantly to cancer development. Recent studies have demonstrated that oxidative stress could alter the epigenome and, in particular, DNA methylation. This study aimed to explore the potential link between o…

review 2022
doi:10.3390/cancers14030608 ·PMID:35158876

In Spain, 34,331 new cases of colorectal cancer were diagnosed in 2018 and 15,923 individuals died from this disease in the same year. The highest incidence of colorectal cancer is among individuals aged 65-75 years and the physiological co…